Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valeo Pharma Inc T.VPH

Alternate Symbol(s):  T.VPH.DB | VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

TSX:VPH - Post Discussion

Valeo Pharma Inc > Flavonoid drug facts and VPH CEO
View:
Post by oiljack14 on Jul 30, 2020 1:33pm

Flavonoid drug facts and VPH CEO

https://www.nutraingredients.com/Article/2020/04/24/Citrus-extract-may-aid-weight-management-study-finds

Just start thinking of the applications for flavonoid drugs. Here is but one example. Again nothing but the facts. A recent and still not completely validated study has shown that a certain flavonoid based drug is showing the ability to reduce weight management concerns among the clinical patients that participated in the study. It was conducted in South Korea for a French drug maker. Now can you imagine the equity value of this drug once proven! The CEO for VPH has identified and is closing on a deal in this space because he has the deep seated industry knowledge and connections to understand a drug opportunity like this and make it into a major investment win for his share holders. This is but one of the many strong results I have found in this area. You really need to appreciate the CEO for who he is, how he has structured his company, and what he knows about the industry and who he knows to get deals done. IF you put that all together then you will see the big move coming. Don’t believe me?! No matter….insiders must they keep buying and have done no selling! Nothing but the facts!
Be the first to comment on this post
Valeo Pharma Inc